
Patient-centric research: an increasing trend within clinical trials
The pharmaceutical marketplace is undergoing fundamental changes that impact the current business models and the healthcare administration. These changes are driven by market forces but also by the patient desire to have access to relevant information and reduced healthcare costs. What is the meaning of a patient-centric model? What are the benefits, challenges and changes necessary to create a patient-centric system? Our guest speakers will share their views on this new approach.


Guest Speakers

Dr Roch Doliveux,
CEO and Chairman of Executive Committee of UCB
CEO and Chairman of Executive Committee of UCB

Mr Frank Boeye,
Chairman Study Group Brain Tumours Belgium
(Werkgroep Hersentumoren vzw)
Chairman Study Group Brain Tumours Belgium
(Werkgroep Hersentumoren vzw)

Programme
7.00pm
Reception
7.30pm
Lectures and Discussion
8.30pm
Walking Dinner


